NDC 72162-2424-01 - Metformin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72162-2424
- Requested NDC
- 72162-2424-01
- Package NDCs from labels
- 72162-2424-0, 72162-2424-1, 72162-2424-2, 72162-2424-4, 72162-2424-5, 72162-2424-7, 72162-2424-9, 72162-2424-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2026-03-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Metformin - Bryant Ranch Prepack | Bryant Ranch Prepack | 2026-03-17 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72162-2424-0 | Metformin | 1000 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 1000 | 101 | |
| 72162-2424-1 | Metformin | 100 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 100 | 101 | |
| 72162-2424-2 | Metformin | 50 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 50 | 101 | |
| 72162-2424-4 | Metformin | 180 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 180 | 101 | |
| 72162-2424-5 | Metformin | 500 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 500 | 101 | |
| 72162-2424-7 | Metformin | 360 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 360 | 101 | |
| 72162-2424-9 | Metformin | 90 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 90 | 101 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 72162-2424 | METFORMIN (METFORMIN ER 500 MG) TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 100 | Current NDC, 7 package rows | 20241114_c047cf64-467a-40f3-be46-a1926b3b8d56.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72162-2424-0 | EA - Each | 72162-2424 | 91694f90-e166-48bf-80d0-593eab2ceb6d | 1 | 2024-12-10 |
| 72162-2424-1 | EA - Each | 72162-2424 | 2bdfc414-6ffb-436e-9d46-a426b4fa27f6 | 1 | 2024-12-10 |
| 72162-2424-2 | EA - Each | 72162-2424 | 38d3f3d2-30bb-481c-802a-7f04f1ae9494 | 1 | 2024-12-10 |
| 72162-2424-4 | EA - Each | 72162-2424 | 03c13ee4-9c27-4063-b7f0-9c4b648c6e27 | 1 | 2024-12-10 |
| 72162-2424-5 | EA - Each | 72162-2424 | 13b33fbd-50d4-4f73-81c2-4527532e9b82 | 1 | 2024-12-10 |
| 72162-2424-7 | EA - Each | 72162-2424 | 89627c8e-cbeb-45f6-bc2b-6b33eb1c6f91 | 1 | 2024-12-10 |
| 72162-2424-9 | EA - Each | 72162-2424 | 646cbc71-a8bc-4e1a-b569-5e4dfe39af0b | 1 | 2024-12-10 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Metformin | METFORMIN | Ingenus Pharmaceuticals, LLC | 49a0b5c2-ebaf-4c4c-905f-dfd1962ac647 | 2026-04-22 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | Granules Pharmaceuticals Inc. | 2387a618-24d8-4813-aa83-9114edb35374 | 2026-04-16 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | NCS HealthCare of KY, LLC dba Vangard Labs | 0448c618-2f0d-4ed3-866f-74b413cf902d | 2026-04-16 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | Novadoz Pharmaceuticals LLC | 4f890458-be94-4baf-b606-83a097e1e23e | 2026-04-09 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | Precision Dose, Inc. | 60142fb2-16da-4f54-a542-74f9a70b9c8b | 2026-04-08 | Boxed warning, Warnings, Adverse reactions | 860975 860981 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 388ee1e0-a0d2-324d-e063-6394a90a1664 | 2026-03-25 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| dapagliflozin and metformin hydrochloride | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | Ascend Laboratories, LLC | eadcc3ef-f5c2-4a56-a6aa-12909844144e | 2026-03-18 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin | METFORMIN ER 500 MG | Bryant Ranch Prepack | c047cf64-467a-40f3-be46-a1926b3b8d56 | 2026-03-17 | Warnings, Adverse reactions | ANDA209313 72162-2424-2 72162-2424-0 72162-2424-5 72162-2424-9 72162-2424-7 72162-2424-1 72162-2424-4 72162-2424 72162242401 860975 8d9a5ffd-46d2-4aa5-ab60-1eb88842f880 c047cf64-467a-40f3-be46-a1926b3b8d56 786Z46389E |
| Metformin Hydrochloride Oral Solution | METFORMIN HYDROCHLORIDE | MICRO LABS LIMITED | fb90693a-074a-45be-94f4-ed6298b1f4e4 | 2026-03-16 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin HCL | METFORMIN HCL | Direct_Rx | 498ac5fc-14be-d36a-e063-6394a90a3012 | 2026-03-13 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | abd0dad9-5f29-4102-a099-dce7bdddb98b | 2026-03-13 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin hydrochloride | METFORMIN HYDROCHLORIDE | Legacy Pharmaceutical Packaging, LLC | b51da8d7-ab4a-4c40-97c9-88bd379366d1 | 2026-03-11 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin | METFORMIN ER 500 MG | Legacy Pharmaceutical Packaging, LLC | d9e0816d-fd61-1ac2-e053-2995a90a4054 | 2026-03-11 | Warnings, Adverse reactions | ANDA209313 860975 786Z46389E |
| Glipizide and Metformin Hydrochloride | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | A-S Medication Solutions | 4a2d814b-93a1-4487-b789-dbafe9f0ffd3 | 2026-03-07 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | direct rx | c33e24e9-0441-6b94-e053-2a95a90a9c68 | 2026-03-05 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| glyburide-metformin hydrochloride | GLYBURIDE-METFORMIN HYDROCHLORIDE | A-S Medication Solutions | f43c087a-7135-4a79-8463-fe5e9319da91 | 2026-03-03 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | A-S Medication Solutions | 75b25738-31e6-4b58-9d2b-f4a1ab4ab090 | 2026-03-03 | Boxed warning, Warnings, Adverse reactions | 860975 786Z46389E |
| Metformin Hydrochloride Oral Solution | METFORMIN HYDROCHLORIDE | Bionpharma Inc., | 3ab005d4-bc99-4fdb-e063-6394a90a5124 | 2026-02-25 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | Method Pharmaceuticals, LLC. | 4aa880a4-7ec0-9155-e063-6394a90a8f3e | 2026-02-09 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Glyburide and Metformin Hydrochloride | GLYBURIDE AND METFORMIN HYDROCHLORIDE | A-S Medication Solutions | d87dade1-55fe-4e77-91b9-b642022a2b8a | 2026-02-08 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.